Sol-Gel Technologies Ltd. Ordinary Shares (SLGL)
Stock · NASDAQ · Health Care
$68.81as of 8/28/2026
Price chart
Open in TradingViewActive signals
Resistance level
$71.34
Industry
Biotechnology: Pharmaceutical Preparations
About SLGL
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustula…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 28
- Website
- www.sol-gel.com
Fundamentals
- 1-day range
- $66.15$76
- Market cap
- $230.38M
- P/E (trailing)
- —
- P/E (forward)
- -8.93
- EPS (trailing)
- $-0.35
- Dividend yield
- —
- Beta
- 1.18
- Avg. volume
- 45.0K
52-week range
$21$97.97
Next earnings: November 19, 2026 · EPS estimate $-3.01
Forecasts
3 analyst ratings
Buy 90%
Hold 10%
Sell 0%
1-year price forecast
High
$285
+314.2%
Median
$195
+183.4%
Low
$110
+59.9%
Sol-Gel Technologies Ltd. Ordinary Shares Competitors
Chosen by industry and closest market cap.
- SLGLSol-Gel Technologies Ltd. Ordinary Shares$69.41▼ 4.35%Market cap $230.38MP/E —$21$97.97
- ADAGAdagene Inc. American Depositary Shares$3.68▼ 5.64%Market cap $239.77MP/E —$1.3$4.85
- MGNXMacroGenics Inc. Common Stock$4.13▲ 1.23%Market cap $242.81MP/E —$1.29$5.08
- WHWKWhitehawk Therapeutics Inc. Common Stock$4.65▼ 4.52%Market cap $212.98MP/E —$1.76$5.5
- MSLESatellos Bioscience Inc. Common Stock$8.92▼ 7.23%Market cap $203.94MP/E —$7.08$18.98
- VRXAVeraxa Biotech AG Ordinary Shares$1.36▼ 5.56%Market cap $258.78MP/E —$1.32$27.36
- ALXOALX Oncology Holdings Inc. Common Stock$2▼ 2.44%Market cap $259.71MP/E —$0.96$2.66
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| SLGL Sol-Gel Technologies Ltd. Ordinary Shares | $230.38M | — | $69.41 | ▼ 4.35% | $21$97.97 |
| ADAG Adagene Inc. American Depositary Shares | $239.77M | — | $3.68 | ▼ 5.64% | $1.3$4.85 |
| MGNX MacroGenics Inc. Common Stock | $242.81M | — | $4.13 | ▲ 1.23% | $1.29$5.08 |
| WHWK Whitehawk Therapeutics Inc. Common Stock | $212.98M | — | $4.65 | ▼ 4.52% | $1.76$5.5 |
| MSLE Satellos Bioscience Inc. Common Stock | $203.94M | — | $8.92 | ▼ 7.23% | $7.08$18.98 |
| VRXA Veraxa Biotech AG Ordinary Shares | $258.78M | — | $1.36 | ▼ 5.56% | $1.32$27.36 |
| ALXO ALX Oncology Holdings Inc. Common Stock | $259.71M | — | $2 | ▼ 2.44% | $0.96$2.66 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
See the full, filterable feed with live charts on the MarketWall dashboard.